A clinical dilemma exists regarding the type of bone that should be used to replace diseased or traumatized osseous tissue. Oral, plastic, and orthopedic surgeons normally implant viable mineralized endochondral (EC) autografts or demineralized EC allografts. A few clinicians have recognized the disadvantages of using EC bone in craniofacial surgery and advocated the replacement of intramembranous (IM) bone with healthy IM bone. However, controversy and uncertainty surround our understanding of these matrices to induce bone formation. Recent studies have advocated the use of other materials with osteoinductive properties, such as demineralized bone matrix (DBM). The proposed delivery system used in this study included IM bone grafts, DBM, and fixation of the IM bone graft. The purpose of this work was to gain further insights into the mechanism of healing of IM bone, in both the presence and the absence of DBM, and to compare the healing of IM bone grafts with that of DBM alone. Criticalsized (10 x 5 mm), full-thickness bony defects in rabbit parietal bone, devoid of periosteum, were filled with IM bone graft (mandible) alone, demineralized cortical bone matrix (DBM) alone, or combined DBM-IM bone graft, or were left unfilled. Histologic changes were examined 14 days later. The IM bone graft healed through IM ossification with no intermediate cartilage stage. DBM and composite DBM-IM healed through an EC ossification with an intermediate cartilage stage. It is hypothesized that the role of the IM graft is to induce neovascularization into the defect site, and that the undifferentiated mesenchymal cells in the perivascular region of the new blood vessels are induced by the bone morphogenetic protein(s) in the DBM into bone-forming cells.
Introduction
Bone formation occurs by either endochondral (EC) or intramembranous (IM) ossification. In EC ossification, bone replaces a hyaline cartilage model. Long bones, such as the femur and humerus, form initially by this pathway (Mckibbin, 1978) . In IM ossification, bone replaces stromal connective tissue proper, without the intermediate stage of cartilage formation. Both the frontal and parietal bones of the skull vault form via the IM ossification pattem (Fawcett, 1986) .
At present, in the clinic, fresh autogenous EC or IM bone grafts are used to regenerate bone in osseous defects. However, controversy and uncertainty surround our understanding of their ability to induce bone formation. Previous work suggested that subcutaneous implants of both demineralized EC and IM bone matrices induce ossification through an intermediate cartilage formation stage (Reddi and Huggins, 1972) . Recently, Scott and Hightower (1991) demonstrated that implants of demineralized EC bone matrix induced bone formation via a cartilage intermediate stage; however, in contrast to previous work (Reddi and Huggins, 1972; Isaksson and Alberius, 1992) , they found that demineralized IM bone matrix induced bone without an intermediate cartilage stage and proceeded directly through an IM ossification pathway.
Clinical studies have successfully used demineralized bone matrix (DBM) as bone graft material for the treatment of acquired and congenital cranio-maxillofacial and orthopedic defects (Urist, 1976; Glowacki et al., 1981) . This natural biomaterial is utilized in osseous reconstruction because of its ability to induce differentiation of mesenchymal cells within non-skeletal tissue into chondroblasts followed by cartilage and subsequent bone formation (Urist, 1965; Reddi and Huggins, 1972; Chalmers et al., 1975; Tuli and Singh, 1978) . Recent clinical observations confirm some degree of success of composite bone grafting with demineralized bone matrix (DBM) (Johnson et al., 1988; Urist, 1991) . Others (Mulliken and Glowacki, 1980; Sonis et al., 1983) have already used DBM and bone graft combinations clinically and suggested that bone formation induced by the DBM, in conjunction with a suitable delivery I Dcizit Rc,U i(4) 1996 sx steixx max be imopoltant in clinical situatiolns i]reiuiring boore replacemen t and nexx bone formxation. ClinicalIv, an togenous IM bone grafts xxVere used in conjunctioll With derninerahl'ed cortical bone niatiix (1D13M) for the repair of manldibullar and maxillary detfects in humans, x bhile in the laboiratorv, the healing of surigically induced bony defects in rat mandibleks by meanls of IM bone gratts and DBM, xas showxn to progiess througih an intermediate cartilage stage (Rabie CI a., 1994) . It is hx pothesizee that the role of the IM Igiatft is to inriuce neox\asculal1i/ationI intO the defect site, and that the uindiffeien tiated m esenic lih mat cells in the perix ascular-region iof the nevx blood x essels are indLiced b\ the bone moriphogeixetic pi-oteini(s) in the Di3.\ into boneformlin"g cells.
As noted, prex ioris work (Mrlliken and Gloxwacki, 19811;  Soniis ct a!. 1983,; Johiosoni c (a)., I988; U rist, 1991; Rabie ctI 71., 1994) derimonstiated thelraperitic potential for the rise of composite bone grafting xxith clemineralized bone matirix I loxx e-r, the bone iiidritctioll process in this delix erx s\ stem Iem11ains rInrClear, and the r-idelstan1dilig of the uinderixving bone inductioni mechianiisms is incomilplete. The objectix es of the present stricix are to gain ftirthier insights inito the mnechanisim of braling of IM bone graft both in the presencce and in thie absence of DBM, and to compare the healing of IMN bone grafts xith that of DBMI alone. In this wxax a sournd forindatiox mnax be establislhed for the clinical rise of these procedcirLes in the treatment of craniofacial bon0v defects in 11hum1anIs for exampIe, in the repair of alx eolar cletts. IFIiixdatiOll, I folmxxdel, NJ, USA) mixed xx itlx xhole blIioodi rut u, 1IV, ciuuzIiiuid lMI-IAI 1Al li,, 'titm: I Ile IM bonix graft x,xas sandxvichled betvxxec' txo lac eI-s of tixe dexiniileralize'd cortical borte poxdei that xx as mixec'd xx itix x lIole blood, aid fixed in place as, dcscribeci abo\ c' All x ci-rixds xxeire closed x ith 4-0) i loix sitri No atterxipts xx r'i e made l' to sitr tl pL'riOist'i_ix togctlier' Post ipce'atielx, tlxc' rabbits xvere gix en an antibiotic 30) mg/kg boxci xeight, i nm (Clxxtetracxcliixe I dtirochlxo0-ixc') ciai Ix toir 1) daxs andcl foti pain relief T'elixg'sic a() Ig-kg s/c dailx fom txo xekxc .
Materials and methods

Histology
Txxo wxeeks post-scirgicall\ tie anixixals x eire killed xxith l'eixtobarbital Soditcii, i.\ (xo mig/kg bocix %xeight and tlxr' ciefectI,r'xS, illCIUdilr thlec ion xcii Lptissui'exxi' xx 11ix-Vestecd forIhistological ureparationi I issui'es xxcrr fixed in 1() neutral phosphlat-bufferled forixxaliux decalcitiedi in K's I)ecal luid for 2 clays, and doiuble-'ixbccited in C clloicliu-x'amraffix. he Spc'cinixx'ix xx'as ccut into serial couoxal ScrtiOriS x Inix tlxick axixl stained xwithl heuixatoxxliix-phlloxine axid sacfftrixi (Il'S) So that preo steo'lasts and osteCoblaists CoLulIL he idieitified s'eixi-thlin sections stained xxitl toluidille bluI Nci-ex' also performx'ed in tlxc' IM bone graft group. Staining fori possible cartilage formatiou fo()tti tiof LDl3MIoti I Iclim1, if IM Cratl i,t R(71a14t Uk,iill 13i ((c 
Results
Clinical and physical examination All animials remtainted il ccl Ictit healthL tirl-lLighiLit the (Fig. 5b ), a alcian bltie stainiiig shoixed positi\ c r'estults. In the niiddle of t'le defect, abl-Incanit pr-olifer-atinig mesenich\ mial cells, poSiti\ el!, stained fot \ iiiicfitil, appeared bett eet x the particles of lDL3M (Figs. ma, 7c ). Iiifialtiiiatfi-i cells polk tiirpiiol-uiiClear CLtikoctfes (PINIL), cotiltl also be ssecii as a resptlise to the sI-rgiCalkl induced dLfect 5; gVm,'j -1 N *, The groaip treated Nxvith cornbinatioan DBM-IVI graft material was also characterized by EC ossification (Fig 6) Vascular invasion and nex bone foriiatotan occitelled thIuoLghIout (Fig. 6a) , unlike the IM graft alone, whicb wxas localized at the intetface betxxeei the host bone edge and bone graft (Fig. 2) . Islands of chondrocv tes and cartilage matrix were seeni between pieces of DBM and also adjaceiit to the bone grafts (Figs 6b, hc) . Alsa, there xwas an abulidanice of proliferating meseniclivmal tvpe cells present in the niddlce of the defect. Discussion Repair of large bony defects in the craniofacial regioan represents a rnajor challenge for the surgeon, since autogelaous graft mater-ial may nat be ax ailable in sufficieiit amainLts. Recent studies have advocated the use of other materials w ith osteoinductive properties, suclh as deminieralized bone matrix (Urist and Strates, 1970;  Glowacki ct a! , 1981). A novel deliverv system, includinig IM bone grafts, demineralized cortical bone matrix, and fixation of the IM bone graft, wx as used in this study (Rabiet al., 1994) . The rabbit model used in this studv vvas relevaant because the noa-nrafted conitrol defect did nat heal. The area wx as large (10 mm x 5 mm is a significant defect for the parietal bone ot a rabbit) ancd of full thiickiess, and the periosteum wxas totally disrupted and nat replaced, as showni in the control group. Therefore, in this model, healing muist be largelv attributed to the implant material.
Demineralized bone matrix induces newx bone formation in a multi-step cascade (Urist iCt i71., 1982; Vandersteenhoven and Spector, 1983; Reddi ct al., 1987) . The majot phases of osteoinduction are chemataxis, mitosis of mesenclx mal cells bv dax 3, differentiation of host mesenclbymial cells to choaldroblasts bv day 5, and nume-otus chondrocxtes pi-eseiit on days 7 to 8. With the adtx ent of capillary inx asion on dlax 9, chonridiocNtes shoxxed siigns of hxper-tiophiv, and ithe firist signs of mineral formation are evident in the matr-ix of the Ix peitr-opliic cliriidi-ocxte. Bx (Figss. (b, 6b, 6c) . A significant finding in this stud\ is thatIM bonegrafts induced bone formnationi through IMossification (Figs. 2-4 ).
1Ihe present results support the xiewx that IM bone, vxhen used as a graft, hasOsteo-enic potential (Rav and Sabet, 1963) To date, almost all knox i n bonedcer-ix ec d osteoind uctive factors have beeni isolated fioI EC bones andc initiate bone inductionc'io FC ossification Recontiv, a hepar-io-sepihar-ose-bitiidinig, osteoi nductix e factor W as extracted and partialIx putirifiecl firom bovine IM bone matrix,and exhiibitedi amoletulal WLeighltdifferenlt from01 that o0 a comparable OsteointlCutCtix e/CoIdCi-oindrtICti\xe factor isolated from I C bone (Scott cfttl., 1994) Theiir work i s the first demonstration that osteoindictix\e factors max also be piesenlt inl osseous tissue xxhich form-ls initially arid completely :i11 IM ossification,and points to a newx soLitCe of osseous tissue frorn xxhicth sutch fatctors can be isolated Theseresults are x aluable in clinical settings wlher-e it xWould be more appi-opriate to ireplace traulmatized oi diseased IM bone with IM athier than with I C bone (Scott and Hightoxxer, 1991) .
Ilistologic analysis demonstratefd that IM bone grafts imdtLCed bone formatioll eia IM ossification, in contrast to implants of DBM, which intlduced bone oia EC ossification. Althoughl Reddi and Huggins (1972) sugCgested that IM matrix also indtiCes the EC cascade, the presenlt results suppolt the findings of Scott and I ightoxver (1991) , xxhicl also compai-ed the bone-inductixe capacities of F C and IVI deminerali/ed bone matrices. Morphological and radiolabelinig techlniiques demonstrated that implants of l C bone matrix induced bone formation wam EC ossification. In contrast, impIants of IM bone matrix induced bone onlx thlrougIl IM OssifiCatioll. Ou findinlgs support these latter obser\ ations (IFigs 2-4). Some eatr-I Nxork bv Ptritc hard (1946) obserxved that, in 22 of 23 fractures of the parietal bones of rats, healing p roceededl xvith iio ca tilage iiiternmediate stages. hlese findinlgs suggest that the matrix of IM bone diffel s qualitatixely fromil that of EC bone in terms of their respectixe abilities to ind ce cartilage and/or ulitillatel x' bone formation.
The most inter-estinig findinig in this stu dx xxas that combining DBM xxith IM bone altered the healing of IM bone to an EC ossification instead of osteogenic ossification route.
The hypothesis of this study entertained the possibility that the IM atitogenoLis grafts intdtice neo\ asCtIlarizatiotl into the defect area, bringin,g uindifferentiated mesetichxvmaal cells, wxhicth cotild theln be acted UpoIn bv the D)3M to intldice theildifferentiation into chonidr-oblasts. IM atitogenolis girafts ma contribute to angio-enesis and increase bone ingroxx th from host bone margins. li grafts max be calibrated to deplox factors at the p -oper-location and time, and ilti matelv biodegratde to biocompatible prod Ucts as the nexw bone is reaeneiated. Also, fM bone graft may fi nCtioll as a temporary stabilizer tintil x iable osseous continuiitx is obtained as a primi1erfor nexw bone formation, and it max act as a mechaniical barrier to fibroblasts covermig the drira. Fibroblasts max iinterfer-e x ith the process of osteogenesis. Hoxxwexer, results of the prcsent striCIV cotild not directlf srIpport all of these speCUlations. FL-tirer biochemical as i well as quantitatixe analysis xxill foCLis Onl the Litilitx of the J Dent Res 75(4) 1996 composite DBM-IM group both experimentally and clinically. Furthermore, the fact that the method of fixation used in this study was not rigid fixation could have affected the healing of the IM group to adopt an endochondral ossification route. However, healing of the IM group showed an osteogenic route, while that of the DBM-IM group showed an EC ossification route. Since the healing of the DBM-alone group showed a cartilage intermediate, then the endochondral ossification in the DBM-IM group is more likely to be due to the effect of the DBM and not due to the non-rigid fixation. It is well-known that DBM induces new bone formation (Urist et al., 1967) . Urist and others demonstrated this potent osteogenic promoter in the reconstruction of skeletal defects (Urist, 1976; Tuli and Singh, 1978; Takagi and Urist, 1982; Wittbjer, 1983) . However, DBM was not used in combination with IM autogenous bone grafts. The advantage of DBM is thought to be due to the content and diffusibility of activated graft bone-bound TGF-3 (a member of the bone morphogenetic protein family) and other growth factors that interact with undifferentiated osteogenic precursor cells in the host bed (Wozney et al., 1988; Urist, 1989) , thus causing them to proliferate and differentiate into functional chondrocytes and osteoblasts (Harakas, 1984; Wozney et al., 1988; Urist, 1989) . Conceptually, then, such IM graft-DBM composites should retain more normal biomechanical properties; however, the literature provides no clues as to the healing of such composite grafts. In the present study, the histologic analysis of the DBM-IM grafted implants showed that the healing was characterized by EC ossification (Fig. 6 ). This suggested that DBM could be a useful supplementary osteoinductivecompetent material. Since DBM could not diffuse into the IM bone when mixed with it, cartilege never developed within the IM-grafted vascular canals. The question remains why the DBM-IM-grafted implants healed through EC ossification. It is probably because the resident mesenchymal cells have osteogenetic determination. Osteogenetic competence or determination is a state of readiness but not yet activated capacity of mesenchymal cells to differentiate into bone cells. The basis of osteogenetic competence is a group of gene-action systems for production of cartilage, bone, and bone marrow cells. Determination of bone cell specialization is therefore a heritable or genetic property (Urist and Strates, 1971) . It should be stated that the DBM-IM composite-material consistently facilitated the thickest, most stable, and optimal contour-preserving bone tissue repair.
The significance of these results is best appreciated when considered in light of recent advances in osseous repair. The osteoinductive proteins, bone morphogenetic protein and osteogenin, have been shown to induce complete osseous repair in similar defects. Germane to the present results are the indications from these and other studies that have proven that the clinical effectiveness of osteoinduced bony repair requires some type of existing defect-filling material. Not only does this filling material prevent tissue collapse into the defect during the healing phase, but it also acts as a scaffolding and potential carrier vehicle.
Reconstruction of large skeletal defects by implanting DBM without a skeletal substitute has been reported to be associated with incomplete bridging in 19% and 25% of the implants, respectively, where either allogeneic or autologous DBM was used (Tuli and Singh, 1978; Wittbjer, 1983) . Previous experimental studies indicated that the combination of a bone-inductive substance and a nonviable bone graft may be an advantage for reconstructing large skeletal defects (Yang et al., 1994) . It was hypothesized that the biological success of a mineralized bone allograft might be enhanced by surrounding it with osteoinductive bone material. Also, Kohler and Kreicbergs (1987) and Kohler et al. (1990) reported that DBM supplements improved the osteogenicity of autoclaved autografts and frozen allografts in rabbit ulnae and humeri. Clinically, it has been suggested that patients with bone defects greater than 4 to 6 cm have been considered poor candidates for cancellous bone grafting because of the high rate of refracture and non-union (Enneking et al., 1980; Moore et al., 1983; Goldstrohm et al., 1984) . Johnson et al. (1988) reported that six patients with traumatic segmental 3to 17-cm tibial defects developed solid union by implantation of (recombinant) hBMP and autogeneic cancellous grafts and stabilization. The properties that are required for an effective graft material (Gepstein et al., 1987) are: (1) the recruitment of osteogenetic precursor cells to the site of new-bone formation, (2) the support of attachment of these cells to a substrate so that they can proliferate, (3) the induction of differentiation of the resident stromal cells to form bone, and (4) neovascularization for support of the newly formed bone. The present proposed delivery system has these characteristics.
Because of the factors present in IM bone, and the osteoinductive factors in DBM, this system, if confirmed by further experimentation, would be of critical value to clinicians who intend to use this system to repair nonregenerative bony defects. Future studies are indicated to determine the long-term efficacy of this delivery system, and we will continue to explore and investigate the fundamental biochemical principles governing these complex processes.
